Targets of Chloroacetaldehyde (cas 107-20-0)-induced nephrotoxicity

Add time:08/20/2019    Source:sciencedirect.com

Chloroacetaldehyde, one of the main products of hepatic ifosfamide metabolism, contributes to its nephrotoxicity. However, the pathophysiology of this toxicity is not fully understood. The present work examined the time and dose effects of clinically relevant concentrations of chloroacetaldehyde (25–75 μM) on precision-cut rat renal cortical slices metabolizing a physiological concentration of lactate. Chloroacetaldehyde toxicity was demonstrated by the decrease in total glutathione and cellular ATP levels. The drop of cellular ATP was linked to the inhibition of oxidative phosphorylation at the level of complex I of the mitochondrial respiratory chain. The large decrease in glucose synthesis from lactate was explained by the inhibition of some gluconeogenic enzymes, mainly glyceraldehyde 3-phosphate dehydrogenase. The decrease in lactate utilization was demonstrated not only by a defect of gluconeogenesis but also by the decrease in [14CO2] formation from [U-14C]-lactate. All the effects of chloroacetaldehyde were concentration and time-dependent. Finally, the chloroacetaldehyde-induced inhibition of glyceraldehyde 3-phosphate dehydrogenase, which is also a glycolytic enzyme, suggests that, under conditions close to those found during ifosfamide therapy, the inhibition of glycolytic pathway by chloroacetaldehyde might be responsible, at least in part, for the therapeutic efficacy of ifosfamide.

We also recommend Trading Suppliers and Manufacturers of Chloroacetaldehyde (cas 107-20-0). Pls Click Website Link as below: cas 107-20-0 suppliers

Prev:The response of Escherichia coli to the alkylating agents Chloroacetaldehyde (cas 107-20-0) and styrene oxide
Next:Acrolein and Chloroacetaldehyde (cas 107-20-0): An examination of the cell and cell-free biomarkers of toxicity)